Gregor Krings, MD, PhD

Title(s)Asst Prof of Clin Pathology, Pathology
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer Res Commun. 2024 Jun 26. Maldonado E, Rathmell WK, Shapiro GI, Takebe N, Rodon J, Mahalingam D, Trikalinos NA, Kaleblasty AR, Parikh M, Boerner SA, Balido C, Krings G, Burns TF, Bergsland EK, Munster PN, Ashworth A, LoRusso P, Aggarwal RR. PMID: 38920407.
      View in: PubMed   Mentions:    Fields:    
    2. Percutaneous Balloon-Expandable Stent Implantation to Treat Transverse Aortic Arch Obstruction: Medium- to Long-Term Outcomes of a Retrospective Multicenter Study. Circ Cardiovasc Interv. 2024 Apr 26; e013729. Salavitabar A, Eisner M, Armstrong AK, Boe BA, Chisolm JL, Cheatham JP, Cheatham SL, Forbes T, Jones TK, Krings GJ, Morray BH, Steinberg ZL, Akam-Venkata J, Voskuil M, Berman DP. PMID: 38666384.
      View in: PubMed   Mentions:    Fields:    
    3. The impact of unilateral pulmonary artery stenosis on right ventricular to pulmonary arterial coupling in patients with transposition of the great arteries. Catheter Cardiovasc Interv. 2024 Apr 05. Joosen RS, Voskuil M, Krings GJ, Handoko ML, Dickinson MG, van de Veerdonk MC, Breur JMPJ. PMID: 38577955.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clin Cancer Res. 2024 02 16; 30(4):729-740. Albain KS, Yau C, Petricoin EF, Wolf DM, Lang JE, Chien AJ, Haddad T, Forero-Torres A, Wallace AM, Kaplan H, Pusztai L, Euhus D, Nanda R, Elias AD, Clark AS, Godellas C, Boughey JC, Isaacs C, Tripathy D, Lu J, Yung RL, Gallagher RI, Wulfkuhle JD, Brown-Swigart L, Krings G, Chen YY, Potter DA, Stringer-Reasor E, Blair S, Asare SM, Wilson A, Hirst GL, Singhrao R, Buxton M, Clennell JL, Sanil A, Berry S, Asare AL, Matthews JB, DeMichele AM, Hylton NM, Melisko M, Perlmutter J, Rugo HS, Symmans WF, Van't Veer LJ, Yee D, Berry DA, Esserman LJ. PMID: 38109213; PMCID: PMC10956403.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    5. Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma. Adv Radiat Oncol. 2024 May; 9(5):101448. Chen JJ, Zhu I, Patel A, Krings G, Chen YY, Yuen F, Mukhtar RA, Melisko M, Singer L, Park CC, Prionas ND. PMID: 38550370; PMCID: PMC10965428.
      View in: PubMed   Mentions:
    6. The effects of percutaneous branch pulmonary artery interventions on exercise capacity, lung perfusion, and right ventricular function in biventricular CHD: a systematic review. Cardiol Young. 2024 Mar; 34(3):473-482. Joosen RS, Frissen JPB, van den Hoogen A, Krings GJ, Voskuil M, Slieker MG, Breur JMPJ. PMID: 38258453.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast Cancer Res Treat. 2024 Feb; 204(1):171-179. Schwartz CJ, Khorsandi N, Blanco A, Mukhtar RA, Chen YY, Krings G. PMID: 38091153; PMCID: PMC10806021.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    8. Right ventricular to pulmonary arterial coupling in patients with repaired tetralogy of Fallot: a case series. Eur Heart J Case Rep. 2023 Dec; 7(12):ytad583. Joosen RS, Breur JMPJ, Wessels JN, Krings GJ, Voskuil M, de Man FS, van de Veerdonk MC. PMID: 38046648; PMCID: PMC10691650.
      View in: PubMed   Mentions:
    9. Malignant phyllodes tumour with lymph node metastasis: a diagnostic conundrum resolved by next generation DNA sequencing. Histopathology. 2024 Jan; 84(2):409-411. Schwartz CJ, Krings G, Chen YY. PMID: 37706238.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression. Mod Pathol. 2023 Dec; 36(12):100324. Shamir ER, Bean GR, Schwartz CJ, Vohra P, Wang A, Allard GM, Wolsky RJ, Garcia JJ, Chen YY, Krings G. PMID: 37660928.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    11. Comparison of Four-Dimensional Flow MRI, Two-Dimensional Phase-Contrast MRI and Echocardiography in Transposition of the Great Arteries. Pediatr Cardiol. 2023 Jul 24. Warmerdam EG, Westenberg JJM, Voskuil M, Rijnberg FM, Roest AAW, Lamb HJ, van Wijk B, Sieswerda GT, Doevendans PA, Ter Heide H, Krings GJ, Leiner T, Grotenhuis HB. PMID: 37488239.
      View in: PubMed   Mentions:    Fields:    
    12. Genetic and Immunohistochemical Profiling of Mammary Hidradenoma and Comparison to Mucoepidermoid Carcinoma. Mod Pathol. 2023 Oct; 36(10):100270. Black MA, Neumann NM, Krings G, Najjar S, Troxell ML, Wang A, Devine WP, Vohra P, Gasper C, Chen YY, Cohen JN, Bean GR. PMID: 37422157.
      View in: PubMed   Mentions: 1     Fields:    
    13. Low-grade fibromyxoid sarcoma of the breast: genetic characterization and immunohistochemical comparison to morphologic mimics. Hum Pathol. 2023 09; 139:17-26. Cloutier JM, Moreland A, Wang L, Kunder CA, Allard G, Wang A, Krings G, Charville GW, Bean GR. PMID: 37392946.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior. Mod Pathol. 2023 05; 36(5):100125. Schwartz CJ, Ruiz J, Bean GR, Sirohi D, Joseph NM, Hosfield EM, Jacobs TW, Mukhtar RA, Chen YY, Krings G. PMID: 36870308.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ. . 2022 Nov 24; 615-654. Krings KG, Hwang HH, Chen CY. .
      View in: Publisher Site   Mentions:
    16. Fibroepithelial Lesions. . 2022 Nov 24; 253-330. Krings KG, Chen CY. .
      View in: Publisher Site   Mentions:
    17. Less Common Triple-Negative Breast Cancers. . 2022 Nov 24; 463-573. Vohra VP, Chen CY, Krings KG. .
      View in: Publisher Site   Mentions:
    18. Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial. JAMA Surg. 2022 11 01; 157(11):1034-1041. Osdoit M, Yau C, Symmans WF, Boughey JC, Ewing CA, Balassanian R, Chen YY, Krings G, Wallace AM, Zare S, Fadare O, Lancaster R, Wei S, Godellas CV, Tang P, Tuttle TM, Klein M, Sahoo S, Hieken TJ, Carter JM, Chen B, Ahrendt G, Tchou J, Feldman M, Tousimis E, Zeck J, Jaskowiak N, Sattar H, Naik AM, Lee MC, Rosa M, Khazai L, Rendi MH, Lang JE, Lu J, Tawfik O, Asare SM, Esserman LJ, Mukhtar RA. PMID: 36069821; PMCID: PMC9453630.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. Correction to: Genetic and immunohistochemical profiling of small cell and large cell neuroendocrine carcinomas of the breast. Mod Pathol. 2022 Oct; 35(10):1494-1495. Bean GR, Najjar S, Shin SJ, Hosfield EM, Caswell-Jin JL, Urisman A, Jones KD, Chen YY, Krings G. PMID: 35697932; PMCID: PMC9514987.
      View in: PubMed   Mentions:    Fields:    
    20. A 3D printed pulmonary mock loop for hemodynamic studies in congenital heart disease. Biomed Phys Eng Express. 2022 09 05; 8(6). Conijn M, Wintermans LM, Metselaar R, Ruisch J, Bax EA, van Egmond CAW, Nieuwenstein B, Warmerdam EG, Krings GJ. PMID: 35970091.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Genetic and immunohistochemical profiling of small cell and large cell neuroendocrine carcinomas of the breast. Mod Pathol. 2022 10; 35(10):1349-1361. Bean GR, Najjar S, Shin SJ, Hosfield EM, Caswell-Jin JL, Urisman A, Jones KD, Chen YY, Krings G. PMID: 35590107; PMCID: PMC9514991.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials. Ann Oncol. 2022 08; 33(8):814-823. Marczyk M, Mrukwa A, Yau C, Wolf D, Chen YY, Balassanian R, Nanda R, Parker BA, Krings G, Sattar H, Zeck JC, Albain KS, Boughey JC, Liu MC, Elias AD, Clark AS, Venters SJ, Shad S, Basu A, Asare SM, Buxton M, Asare AL, Rugo HS, Perlmutter J, DeMichele AM, Yee D, Berry DA, Veer LV, Symmans WF, Esserman L, Pusztai L, I-SPY Consortium. PMID: 35513244.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    23. Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy. Arch Pathol Lab Med. 2022 05 01; 147(5):591-603. Sahoo S, Krings G, Chen YY, Carter JM, Chen B, Guo H, Hibshoosh H, Reisenbichler E, Fan F, Wei S, Khazai L, Balassanian R, Klein ME, Shad S, Venters SJ, Borowsky AD, Symmans WF, Ocal IT. PMID: 35976643.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial. JAMA Oncol. 2021 Nov 01; 7(11):1654-1663. Symmans WF, Yau C, Chen YY, Balassanian R, Klein ME, Pusztai L, Nanda R, Parker BA, Datnow B, Krings G, Wei S, Feldman MD, Duan X, Chen B, Sattar H, Khazai L, Zeck JC, Sams S, Mhawech-Fauceglia P, Rendi M, Sahoo S, Ocal IT, Fan F, LeBeau LG, Vinh T, Troxell ML, Chien AJ, Wallace AM, Forero-Torres A, Ellis E, Albain KS, Murthy RK, Boughey JC, Liu MC, Haley BB, Elias AD, Clark AS, Kemmer K, Isaacs C, Lang JE, Han HS, Edmiston K, Viscusi RK, Northfelt DW, Khan QJ, Leyland-Jones B, Venters SJ, Shad S, Matthews JB, Asare SM, Buxton M, Asare AL, Rugo HS, Schwab RB, Helsten T, Hylton NM, van 't Veer L, Perlmutter J, DeMichele AM, Yee D, Berry DA, Esserman LJ. PMID: 34529000; PMCID: PMC8446908.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    25. Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection. NPJ Breast Cancer. 2021 May 25; 7(1):59. Glencer AC, Wong JM, Hylton NM, Krings G, McCune E, Rothschild HT, Loveday TA, Alvarado MD, Esserman LJ, Campbell MJ, Campbell MJ. PMID: 34035311; PMCID: PMC8149838.
      View in: PubMed   Mentions: 4  
    26. Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapy. Ann Oncol. 2021 05; 32(5):642-651. Du L, Yau C, Brown-Swigart L, Gould R, Krings G, Hirst GL, Bedrosian I, Layman RM, Carter JM, Klein M, Venters S, Shad S, van der Noordaa M, Chien AJ, Haddad T, Isaacs C, Pusztai L, Albain K, Nanda R, Tripathy D, Liu MC, Boughey J, Schwab R, Hylton N, DeMichele A, Perlmutter J, Yee D, Berry D, Van't Veer L, Valero V, Esserman LJ, Symmans WF. PMID: 33617937.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    27. Abstract PS1-03: Active surveillance for DCIS: Clinical outcomes at 5.6 years mean follow-up. Cancer Research. 2021 Feb 15; 81(4_Supplement):ps1-03-ps1-03. Brabham BC, Mukhtar MR, Liang LA, Kim KP, Hirst HG, Basu BA, Greenwood GH, Freimanis FR, Borowsky BA, Hwang HS, Baehner BR, Krings KG, Hylton HN, Esserman EL. .
      View in: Publisher Site   Mentions:
    28. Abstract PS4-09: Pathologic features of the inter-regimen biopsy predict response to neoadjuvant therapy in the I-SPY 2 TRIAL. Cancer Research. 2021 Feb 15; 81(4_Supplement):ps4-09-ps4-09. Carter CJ, Klein KM, Venters VS, Rabe RK, Ocal OI, Singh SK, Wolf WD, Sahoo SS, Harada HS, Khazai KL, Harigopal HM, Borowsky BA, Krings KG, Balassanian BR, Chen CY, Cole CK, Shad SS, Delson DA, Brown-Swigart BL, Esserman EL, van ‘t Veer vL, Symmans SW. .
      View in: Publisher Site   Mentions:
    29. Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy. Clin Cancer Res. 2021 03 15; 27(6):1778-1791. Ma L, Gonzalez-Junca A, Zheng Y, Ouyang H, Illa-Bochaca I, Horst KC, Krings G, Wang Y, Fernandez-Garcia I, Chou W, Barcellos-Hoff MH. PMID: 33402361; PMCID: PMC7956216.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    30. Low-grade endometrial stromal sarcoma metastatic to the breast: Immunohistochemical and molecular characterization of an unusual mimic of mammary myofibroblastoma. Human Pathology Case Reports. 2020 Nov 1; 22:200447. Elliott ED, Pekmezci PM, Geiersbach GK, Krings KG, Rabban RJ, Zaloudek ZC, Chen CY. .
      View in: Publisher Site   Mentions:
    31. Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial. JAMA Oncol. 2020 09 01; 6(9):1355-1362. I-SPY2 Trial Consortium, Yee D, DeMichele AM, Yau C, Isaacs C, Symmans WF, Albain KS, Chen YY, Krings G, Wei S, Harada S, Datnow B, Fadare O, Klein M, Pambuccian S, Chen B, Adamson K, Sams S, Mhawech-Fauceglia P, Magliocco A, Feldman M, Rendi M, Sattar H, Zeck J, Ocal IT, Tawfik O, LeBeau LG, Sahoo S, Vinh T, Chien AJ, Forero-Torres A, Stringer-Reasor E, Wallace AM, Pusztai L, Boughey JC, Ellis ED, Elias AD, Lu J, Lang JE, Han HS, Clark AS, Nanda R, Northfelt DW, Khan QJ, Viscusi RK, Euhus DM, Edmiston KK, Chui SY, Kemmer K, Park JW, Liu MC, Olopade O, Leyland-Jones B, Tripathy D, Moulder SL, Rugo HS, Schwab R, Lo S, Helsten T, Beckwith H, Haugen P, Hylton NM, Van't Veer LJ, Perlmutter J, Melisko ME, Wilson A, Peterson G, Asare AL, Buxton MB, Paoloni M, Clennell JL, Hirst GL, Singhrao R, Steeg K, Matthews JB, Asare SM, Sanil A, Berry SM, Esserman LJ, Berry DA. PMID: 32701140; PMCID: PMC7378873.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    32. A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population. Breast Cancer Res. 2020 07 31; 22(1):81. Kang T, Yau C, Wong CK, Sanborn JZ, Newton Y, Vaske C, Benz SC, Krings G, Camarda R, Henry JE, Stuart J, Powell M, Benz CC. PMID: 32736587; PMCID: PMC7395362.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    33. A phase Ib trial of the cyclin-dependent kinase inhibitor dinaciclib (dina) in combination with pembrolizumab (P) in patients with advanced triple-negative breast cancer (TNBC) and response correlation with MYC-overexpression. Journal of Clinical Oncology. 2020 May 20; 38(15_suppl):1076-1076. Chien CA, Gliwa GA, Rahmaputri RS, Dittrich DH, Majure MM, Rugo RH, Melisko MM, Munster MP, Park PJ, Moasser MM, Matloubian MM, Lea LT, Rohrberg RJ, Krings KG, Goga GA. .
      View in: Publisher Site   Mentions:
    34. Evaluation of ductal carcinoma in situ grade via triple-modal molecular imaging of B7-H3 expression. NPJ Breast Cancer. 2020; 6:14. Bachawal S, Bean GR, Krings G, Wilson KE. PMID: 32377564; PMCID: PMC7190737.
      View in: PubMed   Mentions: 7  
    35. Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival. Breast Cancer Res Treat. 2020 May; 181(1):23-29. Mukhtar RA, Krings G, Chen YY, Mamounas ME, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Rugo H. PMID: 32240457.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    36. Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance). J Clin Oncol. 2020 04 20; 38(12):1284-1292. Hwang ES, Hyslop T, Hendrix LH, Duong S, Bedrosian I, Price E, Caudle A, Hieken T, Guenther J, Hudis CA, Winer E, Lyss AP, Dickson-Witmer D, Hoefer R, Ollila DW, Hardman T, Marks J, Chen YY, Krings G, Esserman L, Hylton N. PMID: 32125937; PMCID: PMC7164489.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    37. Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis. Mod Pathol. 2020 08; 33(8):1518-1526. Beca F, Krings G, Chen YY, Hosfield EM, Vohra P, Sibley RK, Troxell ML, West RB, Allison KH, Bean GR. PMID: 32123305.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    38. Abstract P3-08-20: The normal breast Active transcriptome associated with future breast cancer risk is driven by a dysregulated adipocyte microenvironment. Cancer Research. 2020 Feb 15; 80(4_Supplement):p3-08-20-p3-08-20. Benz BC, Kang KT, Yau YC, Wong WC, Newton NY, Vaske VC, Benz BS, Krings KG, Camarda CR, Henry HJ, Stuart SJ, Powell PM. .
      View in: Publisher Site   Mentions:
    39. Abstract P6-10-02: Assessing biomarkers to inform treatment de-escalation: Mid-treatment biopsy cellularity predicts pCR in the I-SPY 2 Trial. Cancer Research. 2020 Feb 15; 80(4_Supplement):p6-10-02-p6-10-02. Venters VS, Wolf WD, Brown-Swigart BL, Yau YC, Delson DA, Parker PB, Balassanian BR, Carter CJ, Chen CY, Cole CK, Khazai KL, Klein KM, Kokh KD, Krings KG, Sahoo SS, Wei WJ, Esserman EL, van't Veer vL, Symmans SW. .
      View in: Publisher Site   Mentions:
    40. Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma. Mod Pathol. 2020 06; 33(6):1078-1091. Shamir ER, Chen YY, Krings G. PMID: 31907376.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    41. Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity. Mod Pathol. 2020 06; 33(6):1056-1064. Pareja F, da Silva EM, Frosina D, Geyer FC, Lozada JR, Basili T, Da Cruz Paula A, Zhong E, Derakhshan F, D'Alfonso T, Wen HY, Giri DD, Hayes MM, Krings G, Bhargava R, Palazzo JP, Rakha EA, Hoda SA, Sanders ME, Collins LC, Schnitt SJ, Chen YY, Weigelt B, Jungbluth AA, Reis-Filho JS, Brogi E. PMID: 31896809; PMCID: PMC7286791.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    42. Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast. Am J Surg Pathol. 2019 12; 43(12):1693-1700. Harrison BT, Fowler E, Krings G, Chen YY, Bean GR, Vincent-Salomon A, Fuhrmann L, Barnick SE, Chen B, Hosfield EM, Hornick JL, Schnitt SJ. PMID: 31498178.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    43. Abstract 3314: Normal breast tissue at risk for cancer development: A breast cancer initiating role for mammary adipocytes. Prevention, Early Detection, and Interception. 2019 Jul 1; 3314-3314. Kang KT, Yau YC, Benz BS, Krings KG, Camarda CR, Henry HJ, Powell PM, Benz BC. .
      View in: Publisher Site   Mentions:
    44. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma. J Pathol. 2019 06; 248(2):164-178. Joseph NM, Tsokos CG, Umetsu SE, Shain AH, Kelley RK, Onodera C, Bowman S, Talevich E, Ferrell LD, Kakar S, Krings G. PMID: 30690729.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    45. Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center. Am J Surg Pathol. 2019 03; 43(3):399-408. Shamir ER, Chen YY, Chu T, Pekmezci M, Rabban JT, Krings G. PMID: 30489319.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    46. CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast. Histopathology. 2019 Feb; 74(3):463-473. Bean GR, Krings G, Otis CN, Solomon DA, García JJ, van Zante A, Camelo-Piragua S, van Ziffle J, Chen YY. PMID: 30380176.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    47. Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. Nat Med. 2019 01; 25(1):111-118. Shah KN, Bhatt R, Rotow J, Rohrberg J, Olivas V, Wang VE, Hemmati G, Martins MM, Maynard A, Kuhn J, Galeas J, Donnella HJ, Kaushik S, Ku A, Dumont S, Krings G, Haringsma HJ, Robillard L, Simmons AD, Harding TC, McCormick F, Goga A, Blakely CM, Bivona TG, Bandyopadhyay S. PMID: 30478424; PMCID: PMC6324945.
      View in: PubMed   Mentions: 119     Fields:    Translation:HumansAnimalsCells
    48. DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation. Mod Pathol. 2019 02; 32(2):280-289. Bean GR, Anderson J, Sangoi AR, Krings G, Garg K. PMID: 30266945.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    49. Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma. Mod Pathol. 2019 02; 32(2):290-305. Shamir ER, Devine WP, Pekmezci M, Umetsu SE, Krings G, Federman S, Cho SJ, Saunders TA, Jen KY, Bergsland E, Jones K, Kim GE, Kakar S, Chiu CY, Joseph NM. PMID: 30237525.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    50. Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer. J Natl Cancer Inst. 2018 07 01; 110(7):726-733. Lindström LS, Yau C, Czene K, Thompson CK, Hoadley KA, Van't Veer LJ, Balassanian R, Bishop JW, Carpenter PM, Chen YY, Datnow B, Hasteh F, Krings G, Lin F, Zhang Y, Nordenskjöld B, Stål O, Benz CC, Fornander T, Borowsky AD, Esserman LJ, STO Trialists Group. PMID: 29361175; PMCID: PMC6037086.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    51. Abstract 1957: Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. Experimental and Molecular Therapeutics. 2018 Jul 1; 1957-1957. Shah SK, Bhatt BR, Rotow RJ, Rohrberg RJ, Olivas OV, Hemmati HG, Krings KG, Haringsma HH, Simmons SA, Harding HT, Goga GA, Blakely BC, Bivona BT, Bandyopadhyay BS. .
      View in: Publisher Site   Mentions:
    52. Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma. Mod Pathol. 2018 11; 31(11):1661-1674. Krings G, Chen YY. PMID: 29946183.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    53. EWSR1-NFATC2 gene fusion in a soft tissue tumor with epithelioid round cell morphology and abundant stroma: a case report and review of the literature. Hum Pathol. 2018 11; 81:281-290. Cohen JN, Sabnis AJ, Krings G, Cho SJ, Horvai AE, Davis JL. PMID: 29626598; PMCID: PMC8104452.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    54. 452 (PB-085) The impact of mitotic score versus pleomorphic subtype on disease free survival in invasive lobular carcinoma of the breast. European Journal of Cancer. 2018 Apr 1; 92:s132. Mamounas MM, Wong WJ, Fahrner-Scott FK, Chen CY, Krings KG, Ewing EC, Esserman EL, Alvarado AM, Rugo RH, Mukhtar MR. .
      View in: Publisher Site   Mentions:
    55. Local delivery of hormonal therapy with silastic tubing for prevention and treatment of breast cancer. Sci Rep. 2018 01 08; 8(1):92. Park J, Thomas S, Zhong AY, Wolfe AR, Krings G, Terranova-Barberio M, Pawlowska N, Benet LZ, Munster PN. PMID: 29311658; PMCID: PMC5758798.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    56. HDAC inhibition potentiates immunotherapy in triple negative breast cancer. Oncotarget. 2017 Dec 26; 8(69):114156-114172. Terranova-Barberio M, Thomas S, Ali N, Pawlowska N, Park J, Krings G, Rosenblum MD, Budillon A, Munster PN. PMID: 29371976; PMCID: PMC5768393.
      View in: PubMed   Mentions: 89     Fields:    
    57. Comprehensive analysis of normal adjacent to tumor transcriptomes. Nat Commun. 2017 10 20; 8(1):1077. Aran D, Camarda R, Odegaard J, Paik H, Oskotsky B, Krings G, Goga A, Sirota M, Butte AJ. PMID: 29057876; PMCID: PMC5651823.
      View in: PubMed   Mentions: 260     Fields:    Translation:HumansCells
    58. Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors. Breast Cancer Res. 2017 Sep 11; 19(1):107. Bartelink IH, Prideaux B, Krings G, Wilmes L, Lee PRE, Bo P, Hann B, Coppé JP, Heditsian D, Swigart-Brown L, Jones EF, Magnitsky S, Keizer RJ, de Vries N, Rosing H, Pawlowska N, Thomas S, Dhawan M, Aggarwal R, Munster PN, Esserman LJ, Ruan W, Wu AHB, Yee D, Dartois V, Savic RM, Wolf DM, van 't Veer L. PMID: 28893315; PMCID: PMC5594551.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    59. Myofibroblastic, fibroblastic and myoid lesions of the breast. Semin Diagn Pathol. 2017 Sep; 34(5):427-437. Krings G, McIntire P, Shin SJ. PMID: 28751104.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    60. Fibroepithelial lesions; The WHO spectrum. Semin Diagn Pathol. 2017 Sep; 34(5):438-452. Krings G, Bean GR, Chen YY. PMID: 28688536.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    61. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas. Mod Pathol. 2017 08; 30(8):1086-1099. Krings G, Joseph NM, Bean GR, Solomon D, Onodera C, Talevich E, Yeh I, Grenert JP, Hosfield E, Crawford ED, Jordan RC, van Zante A, Zaloudek C, Shin SJ, Chen YY. PMID: 28548128.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    62. Targeted next-generation DNA sequencing of paired tumor and normal DNA to reveal frequent actionable germline alterations. Journal of Clinical Oncology. 2017 May 20; 35(15_suppl):11575-11575. Korn KW, Yey YI, Van Ziffle VJ, Grenert GJ, Joseph JN, Solomon SD, Laurance LM, Talevich TE, Onodera OC, Krings KG, Stohr SB, Blanco BA, Bastian BB. .
      View in: Publisher Site   Mentions:
    63. The molecular basis of breast cancer pathological phenotypes. J Pathol. 2017 Feb; 241(3):375-391. Heng YJ, Lester SC, Tse GM, Factor RE, Allison KH, Collins LC, Chen YY, Jensen KC, Johnson NB, Jeong JC, Punjabi R, Shin SJ, Singh K, Krings G, Eberhard DA, Tan PH, Korski K, Waldman FM, Gutman DA, Sanders M, Reis-Filho JS, Flanagan SR, Gendoo DM, Chen GM, Haibe-Kains B, Ciriello G, Hoadley KA, Perou CM, Beck AH. PMID: 27861902; PMCID: PMC5499709.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    64. Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2017 01; 161(1):17-28. Campbell MJ, Campbell MJ, Baehner F, O'Meara T, Ojukwu E, Han B, Mukhtar R, Tandon V, Endicott M, Zhu Z, Wong J, Krings G, Au A, Gray JW, Esserman L. PMID: 27785654; PMCID: PMC5225037.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    65. 'Non-classical' HER2 FISH results in breast cancer: a multi-institutional study. Mod Pathol. 2017 02; 30(2):227-235. Ballard M, Jalikis F, Krings G, Schmidt RA, Chen YY, Rendi MH, Dintzis SM, Jensen KC, West RB, Sibley RK, Troxell ML, Allison KH. PMID: 27739440.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    66. Abstract 2673: Inhibition of fatty-acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer. Molecular and Cellular Biology, Genetics. 2016 Jul 15; 2673-2673. Camarda CR, Zhou ZA, Kohnz KR, Balakrishnan BS, Mahieu MC, Anderton AB, Eyob EH, Kajimura KS, Tward TA, Krings KG, Nomura ND, Goga GA. .
      View in: Publisher Site   Mentions:
    67. Proliferative index facilitates distinction between benign biliary lesions and intrahepatic cholangiocarcinoma. Hum Pathol. 2016 11; 57:61-67. Tsokos CG, Krings G, Yilmaz F, Ferrell LD, Gill RM. PMID: 27396933; PMCID: PMC5250508.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    68. Small-cell predominant extranodal NK/T cell lymphoma, nasal type: clinicopathological analysis of a series of cases diagnosed in a Western population. Histopathology. 2016 Oct; 69(4):667-79. McKelvie PA, Climent F, Krings G, Hasserjian RP, Abramson JS, Pilch BZ, Harris NL, Ferry JA, Zukerberg LR, Sohani AR. PMID: 27144366.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    69. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity. Mod Pathol. 2016 09; 29(9):1012-27. Liu SY, Joseph NM, Ravindranathan A, Stohr BA, Greenland NY, Vohra P, Hosfield E, Yeh I, Talevich E, Onodera C, Van Ziffle JA, Grenert JP, Bastian BC, Chen YY, Krings G. PMID: 27255162.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    70. SOX2 O-GlcNAcylation alters its protein-protein interactions and genomic occupancy to modulate gene expression in pluripotent cells. Elife. 2016 Mar 07; 5:e10647. Myers SA, Peddada S, Chatterjee N, Friedrich T, Tomoda K, Krings G, Thomas S, Maynard J, Broeker M, Thomson M, Pollard K, Yamanaka S, Burlingame AL, Panning B. PMID: 26949256; PMCID: PMC4841768.
      View in: PubMed   Mentions: 34     Fields:    Translation:AnimalsCells
    71. Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer. Nat Med. 2016 04; 22(4):427-32. Camarda R, Zhou AY, Kohnz RA, Balakrishnan S, Mahieu C, Anderton B, Eyob H, Kajimura S, Tward A, Krings G, Nomura DK, Goga A. PMID: 26950360; PMCID: PMC4892846.
      View in: PubMed   Mentions: 259     Fields:    Translation:HumansCells
    72. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type. Am J Surg Pathol. 2016 Mar; 40(3):419-32. Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT. PMID: 26551622.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    73. Abstract PD3-05: Inhibition of fatty-acid oxidation as a therapy for triple-negative breast cancer. Poster Discussion Abstracts. 2016 Feb 15; pd3-05-pd3-05. Goga GA, Camarda CR, Zhou ZA, Kohnz KR, Balakrishnan BS, Anderton AB, Mahieu MC, Eyob EH, Krings KG, Nomura ND. .
      View in: Publisher Site   Mentions:
    74. Fibroepithelial Lesions. A Comprehensive Guide to Core Needle Biopsies of the Breast. 2016 Jan 1; 241-319. Krings KG, Chen CY. .
      View in: Publisher Site   Mentions:
    75. Less Common Triple Negative Breast Cancers. A Comprehensive Guide to Core Needle Biopsies of the Breast. 2016 Jan 1; 445-518. Vohra VP, Krings KG, Chen CY. .
      View in: Publisher Site   Mentions:
    76. Abstract C61: Non-homogeneous drug penetrance of veliparib measured in triple negative breast tumors. Drug Metabolism, Transport, and Biodistribution. 2015 Dec 1; c61-c61. Bartelink BI, Prideaux PB, Krings KG, Wilmes WL, Lee LP, Hann HB, Coppé CJ, Heditsian HD, Swigart-Brown SL, Jones JE, Magnitsky MS, Keizer KR, Esserman EL, Ruan RW, Wu WA, Yee YD, Dartois DV, Wolf WD, Savic SR, vantVeer vL. .
      View in: Publisher Site   Mentions:
    77. Spatial distribution of veliparib measured by matrix-assisted laser desorption ionization mass spectrometry in triple-negative breast cancer tumors. Journal of Clinical Oncology. 2014 Sep 10; 32(26_suppl):161-161. Bartelink BI, Prideaux PB, Hann HB, Krings KG, Coppe CJ, Brown Swigart BL, Lee LE, Esserman EL, Yee YD, Wolf WD, Savic SR. .
      View in: Publisher Site   Mentions:
    78. Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer. Hum Pathol. 2014 Nov; 45(11):2225-32. Krings G, Nystrom M, Mehdi I, Vohra P, Chen YY. PMID: 25150746.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    79. Predictive biomarkers of invasive carcinoma on excision in patients with a diagnosis of ductal carcinoma in situ of the breast by needle biopsy. Journal of Clinical Oncology. 2014 May 20; 32(15_suppl):e12029-e12029. Mori MM, Krings KG, Chan CL, Wolf WD, Chen CY, Kerlikowske KK, Tlsty TT, Coppe CJ, Matsuda MN, Suzuki SK, Nakamura NS, van't Veer vL. .
      View in: Publisher Site   Mentions:
    80. Aberrant centrizonal features in chronic hepatic venous outflow obstruction: centrilobular mimicry of portal-based disease. Am J Surg Pathol. 2014 Feb; 38(2):205-14. Krings G, Can B, Ferrell L. PMID: 24418854.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    81. Abstract P5-16-04: Predictive biomarkers for invasion on final pathology in patients with preoperative diagnosis of ductal carcinoma in situ of the breast by needle biopsy. Poster Session Abstracts. 2013 Dec 15; p5-16-04-p5-16-04. Mori MM, Krings KG, Chan CL, Chen CY, Kerlikowske KK, Tlsty TT, Matsuda MN, Suzuki SK, van't Veer vL. .
      View in: Publisher Site   Mentions:
    82. Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma. Mod Pathol. 2013 Jun; 26(6):782-91. Krings G, Ramachandran R, Jain D, Wu TT, Yeh MM, Torbenson M, Kakar S. PMID: 23348905.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    83. Ocular melanoma metastatic to the pancreas after a 28-year disease-free interval. Surgery. 2010 Jul; 148(1):151-4. Vagefi PA, Stangenberg L, Krings G, Forcione DG, Wargo JA. PMID: 19744448.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    84. Replication termination mechanism as revealed by Tus-mediated polar arrest of a sliding helicase. Proc Natl Acad Sci U S A. 2008 Sep 02; 105(35):12831-6. Bastia D, Zzaman S, Krings G, Saxena M, Peng X, Greenberg MM. PMID: 18708526; PMCID: PMC2529109.
      View in: PubMed   Mentions: 24     Fields:    Translation:Cells
    85. Molecular architecture of a eukaryotic DNA replication terminus-terminator protein complex. Mol Cell Biol. 2006 Nov; 26(21):8061-74. Krings G, Bastia D. PMID: 16940176; PMCID: PMC1636744.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    86. Sap1p binds to Ter1 at the ribosomal DNA of Schizosaccharomyces pombe and causes polar replication fork arrest. J Biol Chem. 2005 Nov 25; 280(47):39135-42. Krings G, Bastia D. PMID: 16195226.
      View in: PubMed   Mentions: 42     Fields:    Translation:AnimalsCells
    87. swi1- and swi3-dependent and independent replication fork arrest at the ribosomal DNA of Schizosaccharomyces pombe. Proc Natl Acad Sci U S A. 2004 Sep 28; 101(39):14085-90. Krings G, Bastia D. PMID: 15371597; PMCID: PMC521093.
      View in: PubMed   Mentions: 71     Fields:    Translation:AnimalsCells
    88. Chlamydophila pneumoniae induces ICAM-1 expression in human aortic endothelial cells via protein kinase C-dependent activation of nuclear factor-kappaB. Circ Res. 2003 May 30; 92(10):1130-7. Vielma SA, Krings G, Lopes-Virella MF. PMID: 12714566.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    89. Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies. Clin Immunol. 2000 May; 95(2):135-44. Virella G, Koskinen S, Krings G, Onorato JM, Thorpe SR, Lopes-Virella M. PMID: 10779407.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    Gregor's Networks
    Concepts (333)
    Derived automatically from this person's publications.
    Co-Authors (102)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department